News
Events
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact
Events
Read our news
About Pompe Disease
Symptoms
Diagnosis
Pompe Registry
Resources
Patient-Focused Publications
Patients Helping Patients
Research Papers
Publications for Physicians
Testimonials
International Pompe Day
IPA Erasmus Pompe Survey
About the IPA
IPA Board
IPA Members & Contacts
IPA Community Advisory Board
IPA Reviews & Reports
IPA Conferences
IPA Position Papers
Contact us
My Life with Pompe: Overcoming the Challenges and Living Life
By Tiffany House I was diagnosed with Pompe disease when I was 11. It shocks me sometimes when...
Author:
Tiffany House
Archive
April 14, 2017
Be creative!
Your tips and tricks could be displayed here…
Author:
Webmaster
Archive
April 14, 2017
2017 Talent of Pompe (ToP) Awards
To celebrate International Pompe Day on 15th April 2017, IPA has expanded the annual art contest to include...
Author:
Webmaster
Archive
March 5, 2017
Valerion Therapeutics Demonstrates a New Mechanism for Treating Pompe Disease
Concord, MA– March 3, 2017– Valerion Therapeutics announced today that it has developed a fusion protein, VAL-1221, which...
Author:
Valerion
Archive
March 4, 2017
Program Update for Phase 1/2 Pompe Study by Amicus Therapeutics
CRANBURY, N.J., March 01, 2017 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD)… provided program updates. John F. Crowley, Chairman...
Author:
Amicus
Archive
March 2, 2017
Amicus Therapeutics Presents Additional Positive Preliminary Phase 1/2 Data
CRANBURY, N.J. and SAN DIEGO, Feb. 15, 2017 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD)… today presented additional positive...
Author:
Amicus
Archive
February 16, 2017
Amicus Therapeutics Presents Scientific Findings and Preclinical Data for Pompe Program
CRANBURY, N.J. and SAN DIEGO, Feb. 15, 2017 (GLOBE NEWSWIRE) — Amicus Therapeutics (Nasdaq:FOLD)… today presented new scientific...
Author:
Amicus
Archive
February 16, 2017
Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease
Amicus Therapeutics Announces Positive Preliminary Data from Phase 1/2 Study of Novel Treatment Paradigm for Pompe Disease CRANBURY,...
Author:
Amicus
Archive
December 8, 2016
10 Years of Enzyme Replacement Therapy
At the “Steps Forward in Pompe Disease” 8th European Symposium on November 11-12, 2016 in Amsterdam (NL), organised by...
Author:
IPA
Archive
November 12, 2016
NeoGAA Phase 3 Trial Begins
Sanofi Genzyme Begins Pivotal Phase 3 Trial of NeoGAA Investigational Second-Generation Therapy for Pompe Disease In a press...
Author:
Genzyme
Archive
November 4, 2016
1
…
3
4
5
6
7
…
38